Area of research
Cardiology and Cardiovascular Medicine · Surgery
Research interest
Research interests include Cardiac Health and Mental Health, Blood Pressure and Hypertension Studies, Lipoproteins and Cardiovascular Health, and Health Promotion and Cardiovascular Prevention.
[Evaluation of the effectiveness of an intervention for the deprescription of aspirin in primary prevention of cardiovascular diseases].
Periodontal diseases and cardiovascular diseases, diabetes, and respiratory diseases: Summary of the consensus report by the European Federation of Periodontology and WONCA Europe
Periodontal diseases and cardiovascular diseases, diabetes, and respiratory diseases: Summary of the consensus report by the European Federation of Periodontology and WONCA Europe.
Association between periodontal diseases and cardiovascular diseases, diabetes and respiratory diseases: Consensus report of the Joint Workshop by the European Federation of Periodontology (<scp>EFP</scp>) and the European arm of the World Organization of Family Doctors (<scp>WONCA</scp> Europe)
An international multidisciplinary consensus statement on MAFLD and the risk of CVD
Association between periodontal diseases and cardiovascular diseases, diabetes and respiratory diseases: Consensus report of the Joint Workshop by the European Federation of Periodontology (EFP) and the European arm of the World Organization of Family Doctors (WONCA Europe).
Prevalence of Post COVID-19 Condition in Primary Care: A Cross Sectional Study.
Effectiveness and Cost-Effectiveness of Case Management in Advanced Heart Failure Patients Attended in Primary Care: A Systematic Review and Meta-Analysis.
Effects of a Digital Patient Empowerment and Communication Tool on Metabolic Control in People With Type 2 Diabetes: The DeMpower Multicenter Ambispective Study.
Community seroprevalence of COVID-19 in probable and possible cases at primary health care centres in Spain.
Physicochemical Properties of Lipoproteins Assessed by Nuclear Magnetic Resonance as a Predictor of Premature Cardiovascular Disease. PRESARV-SEA Study.
Effectiveness of an Intervention Aimed at Improving Information for Patients with High Cardiovascular Risk: INFORISK Clinical Trial.
[Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Cardiovascular Prevention Guidelines].
Update on cardiovascular prevention in clinical practice: A position paper of the European Association of Preventive Cardiology of the European Society of Cardiology.
Educational Impact on Apixaban Adherence in Atrial Fibrillation (the AEGEAN STUDY): A Randomized Clinical Trial.
A survey to assess awareness and opinion of initiatives and recommendations on low-value diagnostic practices.
[Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Cardiovascular Prevention Guidelines.]
2020cited by 0position: contributor
Unprocessed Red Meat and Processed Meat Consumption: Dietary Guideline Recommendations From the Nutritional Recommendations (NutriRECS) Consortium
Unprocessed Red Meat and Processed Meat Consumption: Dietary Guideline Recommendations From the Nutritional Recommendations (NutriRECS) Consortium.
Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: a novel tool for personalized medicine?
Epidemiology, risk factors, and opportunities for prevention of cardiovascular disease in individuals of South Asian ethnicity living in Europe
Epidemiology, risk factors, and opportunities for prevention of cardiovascular disease in individuals of South Asian ethnicity living in Europe.
Predictive validity of the risk SCORE model in a Mediterranean population with dyslipidemia.
Lifestyle behaviours in patients with established cardiovascular diseases: a European observational study.
A retrospective and prospective 12-month observational study of the socioeconomic burden of moderate to severe irritable bowel syndrome with constipation in Spain.
Estimating the impact of obesity and metabolic phenotype on sickness absence. Results from the ICARIA study.
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial
Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: a novel tool for personalized medicine?
Benchmarking Is Associated With Improved Quality of Care in Type 2 Diabetes
'European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)' The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). [Eur Heart J 2012;33:1635-1701, doi: 10.1093/eurheartj/ehs